Morgan Stanley’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,880,373
Closed -$86M 6845
2017
Q4
$86M Sell
1,880,373
-79,191
-4% -$3.62M 0.02% 664
2017
Q3
$87.9M Buy
1,959,564
+510,912
+35% +$22.9M 0.03% 627
2017
Q2
$43.3M Buy
1,448,652
+588,604
+68% +$17.6M 0.01% 997
2017
Q1
$19.1M Sell
860,048
-101,139
-11% -$2.24M 0.01% 1617
2016
Q4
$18.1M Sell
961,187
-105,560
-10% -$1.99M 0.01% 1638
2016
Q3
$32M Sell
1,066,747
-82,755
-7% -$2.48M 0.01% 1108
2016
Q2
$44.2M Sell
1,149,502
-105,463
-8% -$4.05M 0.02% 862
2016
Q1
$47.8M Buy
1,254,965
+987,755
+370% +$37.6M 0.02% 776
2015
Q4
$11.8M Sell
267,210
-623
-0.2% -$27.4K ﹤0.01% 1830
2015
Q3
$10.9M Buy
267,833
+133,130
+99% +$5.42M ﹤0.01% 1867
2015
Q2
$7.18M Buy
134,703
+33,059
+33% +$1.76M ﹤0.01% 2449
2015
Q1
$6.17M Sell
101,644
-148,872
-59% -$9.03M ﹤0.01% 2548
2014
Q4
$13.1M Buy
+250,516
New +$13.1M ﹤0.01% 1817